Participants:18–64 years
Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
Sponsor:University Of Antwerp

Contact Research Centre

Adenovirus infection

Recruiting

InvestigationalNo placebo

Comparing brincidofovir and cidofovir for treating adenovirus infection in children and adults after stem cell transplantation

InvestigationalNo placebo

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Anhydrous Cidofovir
Sponsor:Symbio Pharmaceuticals Ltd.

Contact Research Centre

Pulmonary tuberculosis

Recruiting

Registered drugNo placebo

Study of bedaquiline, pretomanid, linezolid and moxifloxacin combination treatment for patients with multidrug-resistant tuberculosis in France

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bedaquiline
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Urinary tract infection

Recruiting

Registered drugNo placebo

Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Amikacin Sulfate
Sponsor:Uppsala Universitet

Contact Research Centre

Acarodermatitis

Recruiting

Registered drugNo placebo

Comparing effectiveness of topical permethrin, oral ivermectin, and their combination for treating patients with confirmed scabies infection

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ivermectin
Sponsor:Giuliani S.p.A.

Contact Research Centre

Irritable bowel syndrome

Recruiting

Registered drug

Study of Saccharomyces boulardii CNCM I-745 to treat symptoms in adults with non-constipated Irritable Bowel Syndrome

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Loperamide Hydrochloride
Sponsor:Biocodex

Contact Research Centre

Respiratory syncytial virus infection

Recruiting

Registered drugNo placebo

Study of RSVPreF3 vaccine with AS01E adjuvant in adults aged 60-65 and over 80 years to prevent respiratory syncytial virus infection

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Sponsor:Karolinska Institutet

Contact Research Centre

T-cell type acute leukaemia+2

Recruiting

InvestigationalNo placebo

Study of CART84 Treatment for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Sponsor:Gyala Therapeutics S.L.

Contact Research Centre

Sepsis

Recruiting

Registered drugNo placebo

Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Ampicillin Sodium
Sponsor:Akershus University Hospital

Contact Research Centre

Respiratory syncytial virus infection

Recruiting

Registered drugNo placebo

Study of RSV vaccine immune response persistence and revaccination safety in adult lung and kidney transplant recipients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

COVID-19

Recruiting

Registered drugNo placebo

Study of Remdesivir to Prevent Severe COVID-19 in Kidney Transplant Recipients with No or Mild Symptoms

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Remdesivir
Sponsor:Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La Ciencia

Contact Research Centre

Substances studied in this area

The therapies tested most often in Infections and infestations trials.

Sodium Chloride52 clinical trials Amoxicillin35 clinical trials Emtricitabine32 clinical trials Linezolid32 clinical trials Tenofovir Alafenamide32 clinical trials Clavulanic Acid28 clinical trials Rifampicin25 clinical trials Sulfamethoxazole25 clinical trials Trimethoprim25 clinical trials

Infections and infestations – page 6

Conditions in this area

Clinical trials in Infections and infestations

677 clinical trials

Device related infection+1

Study comparing dalbavancin to standard antibiotic treatment for patients with periprosthetic joint infection

Papilloma viral infection

Study of HPV antibody response in urine samples before and after HPV 9-valent vaccine in people with Human Papillomavirus infection

Adenovirus infection

Comparing brincidofovir and cidofovir for treating adenovirus infection in children and adults after stem cell transplantation

Pulmonary tuberculosis

Study of bedaquiline, pretomanid, linezolid and moxifloxacin combination treatment for patients with multidrug-resistant tuberculosis in France

Urinary tract infection

Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

Acarodermatitis

Comparing effectiveness of topical permethrin, oral ivermectin, and their combination for treating patients with confirmed scabies infection

Irritable bowel syndrome

Study of Saccharomyces boulardii CNCM I-745 to treat symptoms in adults with non-constipated Irritable Bowel Syndrome

Respiratory syncytial virus infection

Study of RSVPreF3 vaccine with AS01E adjuvant in adults aged 60-65 and over 80 years to prevent respiratory syncytial virus infection

T-cell type acute leukaemia+2

Study of CART84 Treatment for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia

Sepsis

Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

Respiratory syncytial virus infection

Study of RSV vaccine immune response persistence and revaccination safety in adult lung and kidney transplant recipients

COVID-19

Study of Remdesivir to Prevent Severe COVID-19 in Kidney Transplant Recipients with No or Mild Symptoms

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.